Korean J Nephrol.
2005 May;24(3):501-509.
Four Cases of Verapamil Deleterious Effects in Chronic Renal Failure
- Affiliations
-
- 1Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea. sooncb@catholic.ac.kr
Abstract
- Four hypertensive patients with chronic renal insufficiency who were treated with sustained release verapamil hydrochloride subsequently developed acute toxic effects. All four patients developed marked bradycardia, hypotension, hyperkalemia and metabolic aciodosis and were treated with atropine, fluid therapy, potasium lowing measure, dialysis, and temporary pacemaker, and were restored to the renal function and sinus rhythm after 12-24 hr. Patients with renal impairement who are treated with sustained release verapamil may accumulate verapamil or its metabolites and develop toxic side effects. We conclude that sustained release verapamil should be used with caution in chronic renal failure and that patients should be closely monitored for adverse cardiovascular, metaboic, and hepatic side effects.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- The effects of intraperitoneal verapamil on beta2-microglobulin in the patients with diagetic renal failure during CAPD
- The effects of verapamil on plasma polyamine in experimental ischemic acute renal failure
- Beneficial Effect of Verapamil Against Ischemic Acute Renal Failure in Rabbits
- Clinical Experience of Hemodialysis on Three Cases of Renal Failure using Kill Type Artificial Kidney
- The effect of verapamil on urinary prostaglandin E2 in experimental ischemic acute renal failure
